Black eyed - Clostridium difficile: An Expert Interview With John G. Bartlett, MD

Clostridium difficile: An Expert Interview With John G. Bartlett, MD
ICAAC 2006: Dr. John G. Bartlett discusses Clostridium difficile: more disease, more serious disease, and more refractory disease.Medscape HIV-AIDSJohn Bartlett

Dermik Laboratories Announces FDA Acceptance Of Supplemental Filing Application For Sculptra(R)
Dermik Laboratories, the dermatology business of sanofi-aventis U.S. LLC, announced today the Food and Drug Administration (FDA) has accepted for filing the company's supplemental premarket approval application (s-PMA) for Sculptra(R) (injectable poly-L-lactic acid) for facial cosmetic use. More than 150,000 people in over 30 countries worldwide have been treated with Sculptra(R), under the trade name NEW-FILL(TM). [click link for full article]

Premium Health Search Engine